COGNUTRIN in Breast Cancer Survivors
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: VitaBlue™|OTHER: Placebo|DRUG: Lovaza®
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Collaborators: Gateway for Cancer Research|University of South Florida